Clinical Trial Update: Fremanezumab for the Prevention of Menstrually-related Migraine Attacks

View source ↗

Summary

ClinicalTrials.gov entry for a study of fremanezumab to prevent menstrually-related migraine attacks; recruiting, sponsored by Insel Gruppe AG and University Ho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menstrual Migraine

Drugs mentioned

• Fremanezumab (fremanezumab)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Menstrual Migraine | Status: RECRUITING